HDAC4 and HDAC5 are mislocalized to the nucleus in neurons from Parkinson’s disease (PD) models, and their pharmacological inhibition show protection on PD-related neurodegenerative features [23, 39]. This evidence concerns the gene HDAC5 and Parkinson disease.